266 related articles for article (PubMed ID: 27600277)
1. Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity.
Heni M; Kullmann S; Ahlqvist E; Wagner R; Machicao F; Staiger H; Häring HU; Almgren P; Groop LC; Small DM; Fritsche A; Preissl H
Diabetologia; 2016 Dec; 59(12):2622-2631. PubMed ID: 27600277
[TBL] [Abstract][Full Text] [Related]
2. DRD2: Bridging the Genome and Ingestive Behavior.
Sun X; Luquet S; Small DM
Trends Cogn Sci; 2017 May; 21(5):372-384. PubMed ID: 28372879
[TBL] [Abstract][Full Text] [Related]
3. Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss.
Haupt A; Thamer C; Machann J; Kirchhoff K; Stefan N; Tschritter O; Machicao F; Schick F; Häring HU; Fritsche A
Obesity (Silver Spring); 2008 Aug; 16(8):1969-72. PubMed ID: 18535549
[TBL] [Abstract][Full Text] [Related]
4. An Obesity-Predisposing Variant of the FTO Gene Regulates D2R-Dependent Reward Learning.
Sevgi M; Rigoux L; Kühn AB; Mauer J; Schilbach L; Hess ME; Gruendler TO; Ullsperger M; Stephan KE; Brüning JC; Tittgemeyer M
J Neurosci; 2015 Sep; 35(36):12584-92. PubMed ID: 26354923
[TBL] [Abstract][Full Text] [Related]
5. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
[TBL] [Abstract][Full Text] [Related]
6. DRD2/ANKK1 TaqI A1 polymorphism associates with overconsumption of unhealthy foods and biochemical abnormalities in a Mexican population.
Rivera-Iñiguez I; Panduro A; Ramos-Lopez O; Villaseñor-Bayardo SJ; Roman S
Eat Weight Disord; 2019 Oct; 24(5):835-844. PubMed ID: 30353454
[TBL] [Abstract][Full Text] [Related]
7. Effect of FTO rs9930506 on obesity and interaction of the gene variants with dietary protein and vitamin E on C-reactive protein levels in multi-ethnic Malaysian adults.
Mitra SR; Tan PY; Amini F
J Hum Nutr Diet; 2018 Dec; 31(6):758-772. PubMed ID: 30141234
[TBL] [Abstract][Full Text] [Related]
8. The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes.
Kowalska I; Malecki MT; Straczkowski M; Skupien J; Karczewska-Kupczewska M; Nikolajuk A; Szopa M; Adamska A; Wawrusiewicz-Kurylonek N; Wołczynski S; Sieradzki J; Gorska M
Diabetes Metab; 2009 Sep; 35(4):328-31. PubMed ID: 19625203
[TBL] [Abstract][Full Text] [Related]
9. Risk of obesity and metabolic syndrome associated with FTO gene variants discloses clinically relevant gender difference among Turks.
Guclu-Geyik F; Onat A; Yuzbasıogulları AB; Coban N; Can G; Lehtimäki T; Erginel-Unaltuna N
Mol Biol Rep; 2016 Jun; 43(6):485-94. PubMed ID: 27146691
[TBL] [Abstract][Full Text] [Related]
10. A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes.
Dubertret C; Bardel C; Ramoz N; Martin PM; Deybach JC; Adès J; Gorwood P; Gouya L
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):492-9. PubMed ID: 20138949
[TBL] [Abstract][Full Text] [Related]
11. The ANKK1 kinase gene and psychiatric disorders.
Ponce G; Pérez-González R; Aragüés M; Palomo T; Rodríguez-Jiménez R; Jiménez-Arriero MA; Hoenicka J
Neurotox Res; 2009 Jul; 16(1):50-9. PubMed ID: 19526298
[TBL] [Abstract][Full Text] [Related]
12. Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and type 2 diabetes susceptibility.
Guigas B; de Leeuw van Weenen JE; van Leeuwen N; Simonis-Bik AM; van Haeften TW; Nijpels G; Houwing-Duistermaat JJ; Beekman M; Deelen J; Havekes LM; Penninx BW; Vogelzangs N; van 't Riet E; Dehghan A; Hofman A; Witteman JC; Uitterlinden AG; Grarup N; Jørgensen T; Witte DR; Lauritzen T; Hansen T; Pedersen O; Hottenga J; Romijn JA; Diamant M; Kramer MH; Heine RJ; Willemsen G; Dekker JM; Eekhoff EM; Pijl H; de Geus EJ; Slagboom PE; 't Hart LM
Diabet Med; 2014 Aug; 31(8):1001-8. PubMed ID: 24724616
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study.
Do R; Bailey SD; Desbiens K; Belisle A; Montpetit A; Bouchard C; Pérusse L; Vohl MC; Engert JC
Diabetes; 2008 Apr; 57(4):1147-50. PubMed ID: 18316358
[TBL] [Abstract][Full Text] [Related]
14. Association between ANKK1 (rs1800497) polymorphism of DRD2 gene and attention deficit hyperactivity disorder: a meta-analysis.
Pan YQ; Qiao L; Xue XD; Fu JH
Neurosci Lett; 2015 Mar; 590():101-5. PubMed ID: 25641135
[TBL] [Abstract][Full Text] [Related]
15. Variation in the FTO gene influences food intake but not energy expenditure.
Haupt A; Thamer C; Staiger H; Tschritter O; Kirchhoff K; Machicao F; Häring HU; Stefan N; Fritsche A
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):194-7. PubMed ID: 19053021
[TBL] [Abstract][Full Text] [Related]
16. Increased recovery rates of phosphocreatine and inorganic phosphate after isometric contraction in oxidative muscle fibers and elevated hepatic insulin resistance in homozygous carriers of the A-allele of FTO rs9939609.
Grunnet LG; Brøns C; Jacobsen S; Nilsson E; Astrup A; Hansen T; Pedersen O; Poulsen P; Quistorff B; Vaag A
J Clin Endocrinol Metab; 2009 Feb; 94(2):596-602. PubMed ID: 18984658
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary consumption as a modifier on the association between FTO gene variants and excess body weight in children from an admixed population in Brazil: the Social Changes, Asthma and Allergy in Latin America (SCAALA) cohort study.
Vilella M; Nunes de Oliveira Costa G; Lima Barreto M; Alexandrina Figueredo C; Maria Alcantara-Neves N; Cunha Rodrigues L; Maria Alvim de Matos S; Leovigildo Fiaccone R; Oliveira P; Rocha A; de Cássia Ribeiro-Silva R
Br J Nutr; 2017 Jun; 117(11):1503-1510. PubMed ID: 28659218
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study.
McAllister TW; Flashman LA; Harker Rhodes C; Tyler AL; Moore JH; Saykin AJ; McDonald BC; Tosteson TD; Tsongalis GJ
Brain Inj; 2008 Aug; 22(9):705-14. PubMed ID: 18698520
[TBL] [Abstract][Full Text] [Related]
19. An obesity-associated risk allele within the FTO gene affects human brain activity for areas important for emotion, impulse control and reward in response to food images.
Wiemerslage L; Nilsson EK; Solstrand Dahlberg L; Ence-Eriksson F; Castillo S; Larsen AL; Bylund SB; Hogenkamp PS; Olivo G; Bandstein M; Titova OE; Larsson EM; Benedict C; Brooks SJ; Schiöth HB
Eur J Neurosci; 2016 May; 43(9):1173-80. PubMed ID: 26797854
[TBL] [Abstract][Full Text] [Related]
20. ROLE OF RS9939609 FTO GENE VARIANT IN WEIGHT LOSS, INSULIN RESISTANCE AND METABOLIC PARAMETERS AFTER A HIGH MONOUNSATURATED VS A HIGH POLYUNSATURATED FAT HYPOCALORIC DIETS.
De Luis DA; Aller R; Izaola O; Pacheco D
Nutr Hosp; 2015 Jul; 32(1):175-81. PubMed ID: 26262713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
